These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 139205)

  • 1. Phase 2 study with Baker's Antifol in solid tumors.
    Rodriguez V; Richman SP; Benjamin RS; Burgess MA; Murphy WK; Valdivieso M; Banner RL; Gutterman JU; Bodey GP; Freireich EJ
    Cancer Res; 1977 Apr; 37(4):980-3. PubMed ID: 139205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F; Correa J; Buroker T; Vaitkevicius VK
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer.
    Krasnow S; Green M; Perry DJ; Eisenberger MA; Johnston-Early A; Muggia F; Cohen MH
    Cancer Treat Rep; 1986 Aug; 70(8):1039-40. PubMed ID: 3524834
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
    Arseneau JC; Bundy B; Dolan T; Homesley H; DiSaia PJ
    Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; LoBuglio A; McCracken J; Pugh R
    Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I studies with Baker's Antifol (BAF) (NSC 139105).
    Rodriguez V; Gottlieb J; Burgess MA; Livingston R; Wheeler W; Spitzer G; Bodey GP; Blumenschein GR; Freireich EJ
    Cancer; 1976 Aug; 38(2):690-4. PubMed ID: 974989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
    Bruckner HW; Lokich JJ; Stablein DM
    Cancer Treat Rep; 1982 Sep; 66(9):1713-7. PubMed ID: 7116348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.
    McCreary RH; Moertel CG; Schutt AJ; O'Connell MJ; Hahn RG; Reitemeier RJ; Rubin J; Frytak S
    Cancer; 1977 Jul; 40(1):9-13. PubMed ID: 141977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas.
    Ajani JA; Dimery I; Chawla SP; Pinnamaneni K; Benjamin RS; Legha SS; Krakoff IH
    Cancer Treat Rep; 1986 Mar; 70(3):375-9. PubMed ID: 3955548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of paclitaxel in gastrointestinal tumors.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

  • 14. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I-II trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule.
    Merlano M; Tatarek R; Grimaldi A; Margarino G; Rosso R
    Cancer Treat Rep; 1985 Sep; 69(9):961-4. PubMed ID: 4040809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of retinol in patients with advanced cancer.
    Goodman GE
    Cancer Treat Rep; 1986 Aug; 70(8):1023-4. PubMed ID: 3731149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.
    Pivot X; Raymond E; Laguerre B; Degardin M; Cals L; Armand JP; Lefebvre JL; Gedouin D; Ripoche V; Kayitalire L; Niyikiza C; Johnson R; Latz J; Schneider M
    Br J Cancer; 2001 Sep; 85(5):649-55. PubMed ID: 11531245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
    Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
    Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.